Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.

Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives

Open access
Xu, Jia, Yang, Pengwei, Xue, Shang, Sharma, Bhuvan, Sanchez-Martin, Marta, Wang, Fang, Beaty, Kirk A., Dehan, Elinor, Parikh, Baiju · 2019 · Human Genetics

Abstract

In the field of cancer genomics, the broad availability of genetic information offered by next-generation sequencing technologies and rapid growth in biomedical publication has led to the advent of the big-data era. Integration of artificial intelligence (AI) approaches such as machine learning, deep learning, and natural language processing (NLP) to tackle the challenges of scalability and high dimensionality of data and to transform big data into clinically actionable knowledge is expanding and becoming the foundation of precision medicine. In this paper, we review the current status and future directions of AI application in cancer genomics within the context of workflows to integrate genomic analysis for precision cancer care. The existing solutions of AI and their limitations in cancer genetic testing and diagnostics such as variant calling and interpretation are critically analyzed. Publicly available tools or algorithms for key NLP technologies in the literature mining for evidence-based clinical recommendations are reviewed and compared. In addition, the present paper highlights the challenges to AI adoption in digital healthcare with regard to data requirements, algorithmic transparency, reproducibility, and real-world assessment, and discusses the importance of preparing patients and physicians for modern digitized healthcare. We believe that AI will remain the main driver to healthcare transformation toward precision medicine, yet the unprecedented challenges posed should be addressed to ensure safety and beneficial impact to healthcare.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00439-019-01970-5

Cites

165 of 165 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Topics discussed in the review paper. This figure demonstrates that several key topics discussed in the paper with the green icons representing benefits or improvements and red icons representing challenges or caveats
Fig. 1 Topics discussed in the review paper. This figure demonstrates that several key topics discussed in the paper with the green icons representing benefits or improvements and red icons representing challenges or caveatsCC BY · PubMed Central
Fig. 2 Publication number plotted against publication year. In this figure, two y-axes have been plotted. One y-axis represents the number for papers related to “Cancer Genomics”. The other y-axis represents the number for papers related to “Cancer Genomics + NLP”. The x-axis represents the publication year
Fig. 2 Publication number plotted against publication year. In this figure, two y-axes have been plotted. One y-axis represents the number for papers related to “Cancer Genomics”. The other y-axis represents the number for papers related to “Cancer Genomics + NLP”. The x-axis represents the publication yearCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 163 references

Research works printed but not linked: 1

  1. Thomas P, Neves M, Solt I, Tikk D, Leser U (2011) relation extraction for drug-drug interactions using ensemble learning. In: Proceedings of the 1st challenge task on drug-drug interaction extraction (DDIExtraction 2011), Huelva, pp 11–18

Cited by

See all 358

Metadata

Authors
Xu, J., Yang, P., Xue, S., Sharma, B., Sanchez-Martin, M., Wang, F., Beaty, K. A., Dehan, E., & Parikh, B.
Affiliations
IBM (United States) (US)
Corresponding author
Xu, Jia
Venue
Human Genetics
Published
2019-01-22
Volume
138
Issue
2
Pages
109-124
ISSN
  • 0018-7348 (ISSN-L)
  • 0340-6717
  • 1432-1203
OpenAlex
W2911526543
Cited by
305
References
163
Citations by year
2026: 33 · 2025: 64 · 2024: 47 · 2023: 38 · 2022: 35 · 2021: 35 · 2020: 40 · 2019: 13
FWCI
1.49
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Human Genetics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
Keywords
cancer genomics, artificial intelligence, precision medicine, variant calling, variant interpretation, cancer genetic testing, natural language processing, literature mining, clinical guidelines, machine learning, deep learning, algorithmic transparency, reproducibility, digital healthcare, next-generation sequencing, big data
MeSH terms
Animals, Electronic Data Processing, Diagnosis, Computer-Assisted, Humans, Natural Language Processing, Neoplasms, Genomics, Data Mining, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives. https://app.cochat.ai/papers/10.1007/s00439-019-01970-5
The paper
Xu, J., Yang, P., Xue, S., Sharma, B., Sanchez-Martin, M., Wang, F., Beaty, K. A., Dehan, E., & Parikh, B. (2019). Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives. Human Genetics. https://doi.org/10.1007/s00439-019-01970-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.